key: cord-0932468-761ash3h
authors: Costa, Rosa; Olea, Beatriz; Bracho, María Alma; Albert, Eliseo; de Michelena, Paula; Martínez-Costa, Cecilia; González-Candelas, Fernando; Navarro, David
title: RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status
date: 2021-12-22
journal: J Infect
DOI: 10.1016/j.jinf.2021.12.018
sha: 47c71866c6720a09f71c925e591be497e8cacd2c
doc_id: 932468
cord_uid: 761ash3h

nan

2 2. SARS-CoV-2 RNA loads were higher for the Delta than the Alpha variant, in both asymptomatic adults and children.

2. For COVID-19 patients, SARS-CoV-2 Delta RNA loads were higher in non-vaccinated individuals compared with vaccinated participants. L452R and P681R), appears to outperform Alpha in terms of replication efficiency in the respiratory tract [2], allegedly resulting in higher viral loads and enhanced transmissibility [3, 4] . Interestingly, Teyssou et al. [5] in a cohort of adults among which Delta variant cases were underrepresented (8%), reported comparable SARS-CoV-2 Delta and Alpha 3 RNA loads in nasopharyngeal specimens (NP) at the time of SARS-CoV-2 infection RT-PCR diagnosis. This observation clearly contrasts with data reported in other studies [6] [7] [8] [9] [10] [11] We initially compared NP viral RNA loads in COVID-19 non-vaccinated individuals stratified by age (children, ≤18 years/adults) and time since symptoms onset (arbitrarily defined as 0-2, 3-7, or ≥8 days). As shown in Fig. 1 , a trend towards higher viral RNA 4 loads was seen for the Delta variant in both adults and children within 2 days after symptoms onset (P=0.27 and P=0.26, respectively), but not afterwards. Nonetheless, a wide range of viral RNA loads (3.-≥11.0 log10 copies/ml) was observed in individuals in comparison groups. In participants asymptomatic at the time of RT-PCT testing, SARS-CoV-2 RNA loads were notably higher for the Delta than the Alpha variant, in both adults (median, 1.5 log10 higher) and children (median, 1.7 log10 higher) (P=0.08 and P=0.01, respectively).

Note that asymptomatic individuals in comparison groups were matched for time elapsed from diagnosis of the index case to RT-PCR testing (within 7 days, as per protocol).

Unfortunately, no data were available regarding as to how asymptomatic infections evolved over time.

As can be seen in Fig. 2 , the slope of the regression line best fitting SARS-CoV-2 RNA load decay in COVID-19 patients was slightly higher overall for the Delta than for the Alpha variant, irrespective of participant age (not shown). Although speculative, the above data could be interpreted as suggesting that peak viral load in NP may be reached earlier in individuals infected by the Delta variant than the Alpha variant: even before symptoms onset, which favors increased transmissibility. In our view the data did not support a more extended period of viral shedding in the upper respiratory tract for the Delta variant, as previously suggested [7] .

We next compared SARS-CoV-2 Delta RNA loads in NP from non-vaccinated (n=128) and fully vaccinated adults (n=51) with Comirnaty® (n=27), Spikevax® (n=9), Janssen® (n=10), or Vaxzebria® (n=5). Time since full-dose vaccination was 51 days (range, 14 -177). Overall, SARS-CoV-2 RNA load was found to be higher in non-vaccinated (n=128; median, 8.1 log10 copies/ml; range, 3.4-11.6) than vaccinated individuals (n=51; median, 7.8 log10 copies/ml; range 3.0-11.2), although without reaching statistical significance 5 (P=0.31). When considering patients with COVID-19 for the analysis (matched for time since symptoms onset: median, 3 days in both groups), a clear trend (P=0.12) towards higher viral RNA loads was observed in non-vaccinated individuals (8.1 log10 copies/ml; range, 3.3-11.6) compared with vaccinated participants (median, 7.4 log10 copies/ml; range, 3.3-11.2).

In contrast, asymptomatic vaccinated and unvaccinated individuals displayed rather In summary, we found substantially higher NP initial viral loads for the Delta than the Alpha variant, in particular during the asymptomatic phase of the infection. Together with the overall lack of significant differences observed between viral loads in vaccinated and unvaccinated Delta-infected participants, this may help explain the epidemiological behavior of the Delta variant. 

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at

The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients

Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)

Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China

Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals

Shedding of Infectious SARS-CoV-2 Despite Vaccination when the Delta Variant is 8

Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community

Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children